Z

Zhejiang Hisun Pharmaceutical Co Ltd
SSE:600267

Watchlist Manager
Zhejiang Hisun Pharmaceutical Co Ltd
SSE:600267
Watchlist
Price: 8.35 CNY -3.24% Market Closed
Market Cap: 9.8B CNY
Have any thoughts about
Zhejiang Hisun Pharmaceutical Co Ltd?
Write Note

Zhejiang Hisun Pharmaceutical Co Ltd
Goodwill

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zhejiang Hisun Pharmaceutical Co Ltd
Goodwill Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Goodwill CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zhejiang Hisun Pharmaceutical Co Ltd
SSE:600267
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Goodwill
ÂĄ104.1m
CAGR 3-Years
45%
CAGR 5-Years
25%
CAGR 10-Years
23%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Zhejiang Hisun Pharmaceutical Co Ltd
Glance View

Market Cap
10.1B CNY
Industry
Pharmaceuticals

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research & development, manufacture, and sale of pharmaceutical products as well as veterinary medicines. The company is headquartered in Taizhou, Zhejiang and currently employs 8,280 full-time employees. The company went IPO on 2000-07-25. The firm's bulk pharmaceutical chemicals mainly include antineoplastic drugs, cardiovascular drugs, anti-infection drugs, endocrine control drugs, anthelmintic, as well as animal remedies, among others. The firm is also engaged in the sales of drugs manufactured by other companies. The firm distributes its products in domestic markets and to overseas markets.

Intrinsic Value
12.71 CNY
Undervaluation 34%
Intrinsic Value
Price
Z

See Also

Back to Top